Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis.
Journal: Journal of affective disorders
Published: December 24, 2025
Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].
Journal: Journal of affective disorders
Published: October 11, 2025
Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.
Journal: The Journal of clinical psychiatry
Published: March 06, 2025
Development of an interactive ultra-high resolution magnetic resonance neurography atlas of the brachial plexus and upper extremity peripheral nerves.
Journal: Clinical imaging
Published: November 15, 2024
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.
Journal: Journal of affective disorders
Published: August 01, 2024
The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression.
Journal: Journal of psychiatric research
Published: May 24, 2024
Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: March 09, 2023
Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.
Journal: Journal of affective disorders
Published: December 16, 2022
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.
Journal: The New England journal of medicine
Published: November 02, 2022
A Randomized, Placebo-Controlled Laboratory Classroom Study of the Efficacy and Safety of Dasotraline in Children With ADHD.
Journal: Journal of attention disorders
Published: January 20, 2022
A Randomized, Double-blind, Placebo-controlled Proof-of-Concept Trial to Evaluate the Efficacy and Safety of Non-racemic Amisulpride (SEP-4199) for the Treatment of Bipolar I Depression.
Journal: Journal of affective disorders
Published: August 24, 2021
Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study.
Journal: Neuropsychiatric disease and treatment
Published: May 19, 2021
Last Updated: 09/26/2026